05.03.22
Stand B80
Sabinsa Corporation will showcase several products at Vitafoods Europe, taking place in Geneva, Switzerland from May 10-12, in addition to presenting a scientific mini-seminar to its customers.
The company will focus on: Curcumin C3 Reduct, the first EFSA approved curcuminoids metabolite; LivLonga, a blend of Curcumin C3 complex, Livinol, and the bioavailability enhancer BioPerine; Cirpusins nutgrass root, standardized to contain 5% stilbenes and formulated to support a healthy BMI; and Shagandha, an ashwagandha root extract which complied with the United States Pharmacopoeia monograph.
The team will demonstrate product concepts including bars, jellies, gummies, and a kombucha drink with the company’s shelf-stable probiotic ingredient LactoSpore, along with a beauty-from-within drink formulated with C3 Reduct and Saberry.
On May 11, at 19:00, Sabinsa will host its scientific mini-seminar at the Hilton Conference Center, where R&D president Dr. Kalyanam Nagabhushanam will speak about Sabinsa’s latest innovations, and Dr. Umar Jan, Sabinsa Europe president, will discuss market trends.
Sabinsa Corporation will showcase several products at Vitafoods Europe, taking place in Geneva, Switzerland from May 10-12, in addition to presenting a scientific mini-seminar to its customers.
The company will focus on: Curcumin C3 Reduct, the first EFSA approved curcuminoids metabolite; LivLonga, a blend of Curcumin C3 complex, Livinol, and the bioavailability enhancer BioPerine; Cirpusins nutgrass root, standardized to contain 5% stilbenes and formulated to support a healthy BMI; and Shagandha, an ashwagandha root extract which complied with the United States Pharmacopoeia monograph.
The team will demonstrate product concepts including bars, jellies, gummies, and a kombucha drink with the company’s shelf-stable probiotic ingredient LactoSpore, along with a beauty-from-within drink formulated with C3 Reduct and Saberry.
On May 11, at 19:00, Sabinsa will host its scientific mini-seminar at the Hilton Conference Center, where R&D president Dr. Kalyanam Nagabhushanam will speak about Sabinsa’s latest innovations, and Dr. Umar Jan, Sabinsa Europe president, will discuss market trends.
